Received Sep 23, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | UNK | — | IM |
Covid-19 in approximately 2024; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Covid-19 in approximately 2024) in a 73-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. On an unknown date, the patient received dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) 1 dosage form. In 2024, the patient experienced COVID-19 (Covid-19 in approximately 2024). At the time of the report, COVID-19 (Covid-19 in approximately 2024) had resolved. Relevant Medical History (vaccines within the past 4 weeks, medical conditions) was reported as none. No concomitant medication was reported. The patient was very healthy. The patient contracted Covid-19 in approximately 2024 after received Moderna's Covid vaccines in the past. She reported that not remembering the dates of her previous Covid vaccinations, it was all a blur. She had COVID once, but she had the shots, so it wasn't as bad as it could be, and she didn't get any long COVID effects. So, Moderna had been pretty good so far for her. Not right after that. She did get it at one point, but she recovered and, it's just a high fever for a few days but no long-term effects from it. No treatment medication was reported.